AtriCure is a provider of treatments for atrial fibrillation and left atrial appendage management. The company provides product lines for left atrial appendage management and open and minimally invasive cardiac tissue ablation. The company's Radio Frequency Ablation devices include; CryoICE Cryoablation System, which is used in open ablation procedures and consists of the cryoICE Box generator along with a single-use disposable probe; EPi-Sense Guided Coagulation System with VisiTrax Technology, which utilizes monopolar energy for the coagulation of tissue; and LARIAT System, which is a suture-based solution for soft-tissue closure and is compatible with a range of anatomical shapes.

Bryn Mawr Bank is a bank holding company. Through its subsidiary, The Bryn Mawr Trust Company (the Bank), the company provides a range of personal and business banking services, consumer and commercial loans, equipment leasing, mortgages, insurance and wealth management services, including investment management, trust and estate administration, retirement planning, custody services, and tax planning and preparation. The Bank is engaged in commercial and retail banking business, providing basic banking services, including the acceptance of demand, time and savings deposits and the origination of commercial, real estate and consumer loans and other extensions of credit including leases.

Carrols Restaurant Group is a holding company. Through its subsidiaries, the company is engaged as a Burger King? franchisee. The company owns and operates Burger King restaurants located in Northeastern, Midwestern and Southeastern states. Burger King restaurants feature the flame-broiled Whopper? sandwich, as well as a variety of hamburgers, chicken and other specialty sandwiches, french fries, salads, breakfast items, snacks, soft drinks and other offerings.

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company's product pipeline includes three clinical candidates: trilaciclib, a short-acting intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor that preserves hematopoietic stem and progenitor cells and immune system function; lerociclib, an oral CDK4/6 inhibitor that inhibits tumor proliferation and growth; and G1T48, an oral selective estrogen receptor degrader that inhibits estrogen receptor driven tumor proliferation.

GreenSky is a holding company. Through its subsidiaries, the company is a technology company Powering Commerce at the Point of SaleSM. The company's platform is powered by a proprietary technology infrastructure that facilitates merchant sales, while reducing the friction, and improving the economics associated with a consumer making a purchase and a bank extending financing for that purchase. It supports the transaction lifecycle, including credit application, underwriting, real-time allocation to the company's Bank Partners, document distribution, funding, settlement and servicing.

Myers Industries manufactures a range of polymer products for industrial, agricultural, automotive, commercial and consumer markets. The company has two business segments: Material Handling and Distribution. The Material Handling segment manufactures polymer packaging containers, storage and safety products, and specialty molded parts. The brands within this segment include Buckhorn?, Akro-Mils?, Jamco Products, Ameri-Kart?, and Scepter. The company's Distribution segment includes the Myers Tire Supply?, Myers Tire Supply International? and Patch Rubber Company? brands. Within the Distribution Segment Co. sources and manufactures products for the tire, wheel and undervehicle service industry.

Organogenesis Holdings is a regenerative medicine company focused on the development, manufacture and commercialization of solutions. The company's Advanced Wound Care products include Apligraf for the treatment of VLUs and DFUs; Dermagraft for the treatment of DFUs; PuraPly Antimicrobial (PuraPly AM) to address biofilm across various wound types; and Affinity and NuShield to address various wound sizes and types. The company's Surgical and Sports Medicine products include ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical application in targeted soft tissue repairs; and PuraPly AM for surgical treatment of open wounds.

Spok Holdings provides a suite of unified clinical communication and collaboration solutions that include call center operations, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications and public safety solutions. The company also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize mission clinical communications. These solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications.

Wayside Technology Group is an information technology channel company. The company provides a line of products from software vendors and tools for virtualization/cloud computing, security, networking, storage and infrastructure management, application lifecycle management and other domains as well as computer hardware. The company's Lifeboat Distribution segment distributes technical software to corporate resellers, value added resellers, consultants and systems integrators. The company's TechXtend segment is a reseller of software, hardware and services, selling to end user corporations, government organizations and academic institutions.